International Society on Thrombosis and Haemostasis

International Society on Thrombosis and Haemostasis
Name	International Society on Thrombosis and Haemostasis
Abbreviation	ISTH
Formation	1969
Type	Learned society
Region served	International
Leader title	President

International Society on Thrombosis and Haemostasis. The International Society on Thrombosis and Haemostasis is a global learned society focused on hemostasis and thrombosis research, clinical practice, and education, engaging clinicians, researchers, and policy makers worldwide. The society convenes multidisciplinary experts from institutions such as Mayo Clinic, Massachusetts General Hospital, King's College London, University of Cambridge, and Karolinska Institutet to advance understanding of coagulation, platelet biology, and vascular medicine. Its community includes members affiliated with organizations like the World Health Organization, European Society of Cardiology, American Society of Hematology, Royal College of Physicians, and numerous national hematology and vascular societies.

History

Founded in 1969 amid growing international interest in coagulation disorders, the society grew contemporaneously with advancements at centers including Harvard Medical School, Johns Hopkins University, University of Oxford, University of Toronto, and UCLA. Early leaders drew on legacies from figures and institutions associated with the development of assays and therapies pioneered at St Thomas' Hospital, Beth Israel Deaconess Medical Center, and Karolinska University Hospital. Over subsequent decades the society expanded its scope in parallel with milestones such as the elucidation of the coagulation cascade by researchers linked to Nobel Prize–associated laboratories and the translation of anticoagulant therapies developed by pharmaceutical innovators connected to Roche, Bayer, and Bristol-Myers Squibb. Its congresses have been held in cities including Vienna, Boston, Tokyo, Melbourne, Paris, and Buenos Aires, reflecting partnerships with regional academies such as the European Hematology Association and national bodies like Japanese Society on Thrombosis and Hemostasis.

Mission and Activities

The society’s mission emphasizes promotion of research and clinical care in thrombosis and hemostasis, interacting with entities such as World Federation of Hemophilia, International Society for Laboratory Hematology, European Society for Vascular Surgery, American College of Cardiology, and International Atomic Energy Agency–affiliated research programs. Core activities include organizing scientific meetings alongside specialty organizations such as the International Stroke Conference, collaborating on registries with institutions like Centers for Disease Control and Prevention, and contributing to global initiatives involving Pan American Health Organization and regional ministries of health. The society runs scientific committees that liaise with groups including COMPASS Trial investigators, RE-LY Trial investigators, and networks tied to European Medicines Agency and Food and Drug Administration regulatory science forums.

Governance and Membership

Governance is overseen by an elected executive committee and council incorporating representatives from universities and hospitals such as Imperial College London, University of Pennsylvania, Sorbonne University, Monash University, and University of São Paulo. Membership categories encompass clinicians, basic scientists, laboratory specialists, trainees, and industry affiliates from companies like Pfizer, AstraZeneca, Merck, Johnson & Johnson, and biotech firms collaborating in consortia. The society conducts elections mirroring practices found at organizations like Royal Society, American Philosophical Society, and European Molecular Biology Organization to ensure geographic representation across regions including Africa, Asia, Europe, Latin America, and North America.

Scientific Publications and Journals

The society publishes peer-reviewed journals and position papers, edited by scholars affiliated with University of California, San Francisco, Utrecht University, University of Bern, McMaster University, and Trinity College Dublin. Major publications draw contributions from investigators associated with trials and cohorts such as Framingham Heart Study, UK Biobank, Icelandic Heart Association, and multicenter initiatives like Global Burden of Disease collaborators. The journals feature original research, reviews, and guideline documents with editorial standards paralleling titles like The Lancet, New England Journal of Medicine, and Blood and engage editorial board members from institutions including Stanford University, Yale University, and King Faisal Specialist Hospital.

Education, Conferences, and Awards

The society organizes annual congresses, focused symposia, and online education in collaboration with partners such as European Society of Cardiology, American Heart Association, International Pediatric Thrombosis Network, and regional academic centers including Seoul National University and University of Cape Town. It administers awards and fellowships named in honor of pioneers linked to institutions like University of Leiden, McGill University, and Hammersmith Hospital and supports trainees through programs modeled on those from Howard Hughes Medical Institute and Wellcome Trust. Conference venues have included global landmarks such as Sydney Opera House–adjacent centers and convention centers in Berlin, Toronto, and Dubai International Convention Centre.

Research and Clinical Guidelines

The society convenes guideline committees that produce recommendations intersecting with clinical trials and regulatory frameworks involving groups like European Heart Journal editors, American College of Chest Physicians, and trial consortia such as EINSTEIN Investigators and Hokusai-VTE Investigators. Guideline development leverages evidence from randomized trials, cohort studies, and translational research undertaken at laboratories throughout networks including Human Genome Project–era collaborators and national institutes like National Institutes of Health and Medical Research Council. Outputs include clinical guidance for diagnosis and management of venous thromboembolism, hemophilia, and thrombocytopenia, designed to be adopted by hospitals and ministries of health in coordination with stakeholders such as World Health Organization, Pan American Health Organization, and regional professional societies.

Category:Medical societies